Taking into account the high prevalence of alterations in the PI3K/AKT signaling pathway and the PTEN tumor suppressor in many types of tumors, our results pinpoint a new relevant factor to potentially improve prognosis and therapeutic approaches across some human neoplasms. This evidence concerns the gene PTEN and neoplasm.